Salvia BioElectronics

medical devices

About

Salvia BioElectronics is a clinical-stage medical device company based in Eindhoven, The Netherlands, founded in 2017. The company specializes in neuromodulation therapies aimed at transforming the treatment of chronic migraine. Its primary product, MySalvia Therapy, is a minimally invasive, ultra-thin implantable device that targets key nerves involved in migraine attacks. This device delivers gentle electrical pulses to help reduce the frequency and intensity of migraines. The MySalvia Therapy is designed to be patient-controlled, allowing users to activate the treatment on demand through a small, wearable external device. Salvia BioElectronics is currently conducting global clinical trials to validate the safety and efficacy of its technology, which has received FDA Breakthrough Device designation. The company is focused on bringing its innovative therapy to market in the United States, Europe, and Australia, supported by significant venture capital funding. Salvia aims to provide individuals suffering from chronic migraines with a drug-free, effective treatment option that integrates seamlessly into their daily lives.

Technologies

Cloudflare DNS Outlook Typekit Mobile Friendly Google Tag Manager WordPress.org Google Font API Remote AI

Keywords

bioelectronics neurostimulation medical devices startups entrepreneurship r d business development neurotechnology medical equipment manufacturing medical device manufacturing wearable device medical device engineering on-demand therapy clinical trials regulatory pathway headache management neurology medical technology fda breakthrough device healthcare equipment & supplies medical device medical equipment and supplies manufacturing implantable medical device clinical development clinical trial europe clinical studies drug-free relief electrical nerve stimulation patient-controlled device

Location

37 High Tech Campus, Eindhoven, North Brabant, Netherlands, 5656 AE

Related Companies

Companies in the same industry